Longboard reports positive data from Phase I LP352 clinical study

The trial findings showed that LP352 exhibited a strong correlation between plasma and CSF PK concentration.

Mirati reports initial data from lung cancer trials

Grade 1-2, Grade 3, and Grade 4 treatment-related adverse events were reported in the trial.

Novartis’ Phase III prostate cancer therapy trial meets primary endpoint

Assessing overall survival, which is the crucial secondary endpoint of the trial, is progressing.

Managing drug shortages: Getting medicines to patients in need

Patients around the world are experiencing drug shortages, with production still recovering from the disruption caused by Covid-19, the war in Ukraine, and rising energy costs. Tanner Pharma is tackling these issues head-on, managing disruptions and ensuring that a range of treatments reach patients wherever they are.

Pipeline Moves: Novartis completes ulcerative colitis trial, advancement prospects rise

The Clinical Trials Arena team also reviews assets in oncology, paediatric hormone deficiency, diabetic pain and ophthalmology.